Non-pegylated and Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma and the Risk of Severe Ocular Side-effects
Abstract is missing (Short communication)
Saved in:
Main Authors: | Jana D. Albrecht (Author), Nadia Ninosu (Author), Denise Barry (Author), Thomas Albrecht (Author), Marthe-Lisa Schaarschmidt (Author), Sergij Goerdt (Author), Jan P. Nicolay (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection
by: Janika Gosmann, et al.
Published: (2023) -
Systematic review and meta-analysis: de novo combination of nucleos(t)ide analogs and pegylated interferon alpha versus pegylated interferon alpha monotherapy for the functional cure of chronic hepatitis B
by: Na Wei, et al.
Published: (2024) -
Pegylated-interferon-alpha treatment modulating the immune response of cytotoxic lymphocytes in cervical intraepithelial neoplasia
by: Letícia Montes Stark, et al.
Published: (2021) -
Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
by: Yasser K. Rashed, et al.
Published: (2020) -
Frequency Of Depressive And Anxiety Symptoms Among Patients On Interferon And Pegylated Interferon
by: Muhammad Waseem Shaikh, et al.
Published: (2024)